China's exports of basic pharmaceutical products and pharmaceutical preparations to Egypt have shown a mixed trend over the years. In 2023, the export value stood at $196.93 million, marking a small year-on-year growth of 3% from $191.19 million in 2022. Over the last two years, the trend has been relatively volatile with a -6.22% decline in 2022 followed by a modest recovery in 2023. The Compound Annual Growth Rate (CAGR) over the last five years stands at 2.39%, indicating moderate overall growth despite yearly fluctuations.
Looking ahead, the forecast predicts steady growth with the export value expected to reach $224.89 million by 2028. The projected five-year CAGR is 1.97%, translating to an overall growth rate of 10.25%. While this represents a positive outlook, it also suggests a slower growth pace compared to earlier years.
Future trends to watch for include:
• Potential regulatory changes in both China and Egypt concerning pharmaceutical imports and exports.
• Technological advancements and their impact on production and supply chain efficiencies.
• Global economic conditions and their influence on international trade dynamics.
• Emerging health issues or pandemics that may drive demand for specific pharmaceutical products.
